Mineralys Therapeutics, Inc.
Company Stats
- Market Cap
- $2.2B
- as of Sep 30, 2026
- Shares Outstanding
- 88.4M
- Free Float
- 66.8%
Income Statement
- Operating Income
- -$170.6M
- Net Income
- -$154.7M
- EBITDA
- -$170.5M
Cash Flow
- Free Cash Flow
- -$142.4M
- FCF Yield
- -6.4%
- Owner FCF Yield
- -7.3%
Balance Sheet
- Cash & Equivalents
- $172.9M
Returns & Capital
- SBC, 3Y Avg
- $11.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$142.4M | — |
| FY2024 | — | -$166.4M | — |
| FY2023 | — | -$81.2M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges